Back to Search
Start Over
Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban.
- Source :
-
International journal of hematology [Int J Hematol] 2016 Feb; Vol. 103 (2), pp. 165-72. Date of Electronic Publication: 2015 Nov 19. - Publication Year :
- 2016
-
Abstract
- Rivaroxaban, which targets factor Xa and does not reduce proteins C/S, was chosen to treat a 6-year-old girl with homozygous protein S (PS) deficiency who developed skin necrosis while on warfarin. Owing to the lack of experience with rivaroxaban in children, the girl was started with 5 mg once-daily, which was gradually increased to 40 mg daily. The increasing dosage was driven by the need to avoid recurrence of skin necrosis. During dose-escalation, four pharmacokinetics assays were carried out measuring drug plasma concentrations and their effect on hemostatic parameters. We report the laboratory work-up, with special reference to parameters of thrombin-generation. Rivaroxaban concentrations by HPLC were correlated with those by the anti-factor Xa assay (r(2) = 0.92, p < 0.01), but there was an overestimation by HPLC. Thrombin-generation parameters, such as the area under the curve (referred to as ETP), peak-thrombin, and velocity-index, when measured after addition of thrombomodulin, showed unexpected changes: ETP decreased, but peak-thrombin and velocity-index increased. Similar patterns were obtained in a PS-depleted plasma and in plasma from patients with heterozygous PS deficiency, but not in plasma from controls. In conclusion, these preliminary results suggest that PS may be a determinant of velocity and peak-thrombin, but not of the total amount of thrombin generated.
- Subjects :
- Child
Factor Xa Inhibitors administration & dosage
Female
Homozygote
Humans
Protein S Deficiency congenital
Protein S Deficiency genetics
Rivaroxaban administration & dosage
Blood Coagulation
Factor Xa Inhibitors therapeutic use
Protein S Deficiency blood
Protein S Deficiency drug therapy
Rivaroxaban therapeutic use
Thrombin metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1865-3774
- Volume :
- 103
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- International journal of hematology
- Publication Type :
- Academic Journal
- Accession number :
- 26586461
- Full Text :
- https://doi.org/10.1007/s12185-015-1898-6